Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Tofacitinib, ATC L04AF01

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jun 03, 2027 · 291 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tofacitinib, ATC L04AF01

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

The open house model is not subject to procurement law; limited legal remedies. Disputes handled by social courts, not...

Failure to follow correct submission method (physical vs. electronic) or missing documents may delay or prevent contrac...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jul 2027
  • Supply of pharmaceutical products containing Tofacitinib (ATC L04AF01) under non-exclusive discount agreements.
  • Contracts are standardized and not individually negotiable.
Show full summary

Open house model for non-exclusive discount agreements (Rabattverträge) on Tofacitinib (ATC L04AF01) by AOK Bayern. Pharmaceutical companies can join at any time until 03.06.2027. Contracts run from 01.08.2025 to 31.07.2027. The procedure is not subject to procurement law; no selection or competition among tenderers.

Risks

The open house model is not subject to procurement law; limited legal remedies. Disputes handled by social courts, not...

Failure to follow correct submission method (physical vs. electronic) or missing documents may delay or prevent contrac...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible.

Administrative

  • Submit signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed self-declaration of reliability.
  • Submission either in physical form (2 copies) with handwritten signature or electronically with qualified electronic signature.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria – open house model, no selection.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Tofacitinib, ATC L04AF01

Open house for non-exclusive discount agreements on Tofacitinib. All eligible pharmaceutical companies may join. Contracts are identical and not individually negotiable. Performance location: Bavaria, Germany.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jul 2025 - Jul 2027

Category

Pharmaceutical products

Award Criteria

No award criteria – open house model, no selection.

Deadline

Deadline Jun 03, 2027

Procurement Details

Publication date
15 Jun 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
387344-2025

Documents (2)

Similar tenders